Ginsengberg
@xiangzijiang
In Japan, traditional Chinese medicine (TCM) follows a "preserve the medicine, discard the doctor" approach, mainly used as adjunctive therapy in Western medical treatment. Regarding EKAT (Evidence Reports of Kampo Treatment), which includes randomized controlled trials (RCTs) on Kampo medicine, you may refer to this summary: 「#日本東洋医学会 #漢方治療エビデンスレポート (EKAT)」，
1 reply
0 recast
0 reaction
Ginsengberg
@xiangzijiang
This report from the Japan Society for Oriental Medicine extensively lists RCTs on Kampo medicines. Specifically, this section presents research findings on the use of Juzentaihoto (十全大補湯), highlighting its potential benefits in the following scenarios:Improves survival rates in patients with progressive breast cancer, especially those considered suitable for Juzentaihoto in Kampo medicine.Selectively increases the conversion of Tegafur to 5-FU (a chemotherapy drug) in tumor tissues.Reduces the risk of developing liver cancer in patients with liver cirrhosis.Lowers the risk of liver cancer and improves survival rates in patients with liver cirrhosis.Extends postoperative survival in patients with stage III and IV gastric cancer.
1 reply
0 recast
0 reaction
Ginsengberg
@xiangzijiang
Alleviates side effects in cancer patients undergoing radiation therapy.Reduces nausea and vomiting in patients with hepatocellular carcinoma after receiving transcatheter arterial embolization therapy with Spongel, Lipiodol, Phosphatidylcholine, and Cisplatin.Decreases the frequency of chemotherapy-induced leukopenia (white blood cell reduction) and delays its onset.Eases the side effects of chemotherapy in cancer patients.
0 reply
0 recast
0 reaction